BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 32786318)

  • 1. Design, Synthesis, and Functional Evaluation of a Novel Series of Phosphonate-Functionalized 1,2,3-Triazoles as Positive Allosteric Modulators of α7 Nicotinic Acetylcholine Receptors.
    Nielsen BE; Stabile S; Vitale C; Bouzat C
    ACS Chem Neurosci; 2020 Sep; 11(17):2688-2704. PubMed ID: 32786318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flavonoids as positive allosteric modulators of α7 nicotinic receptors.
    Nielsen BE; Bermudez I; Bouzat C
    Neuropharmacology; 2019 Dec; 160():107794. PubMed ID: 31560909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the positive allosteric modulation of human α7 nicotinic receptors from a single-channel perspective.
    Andersen ND; Nielsen BE; Corradi J; Tolosa MF; Feuerbach D; Arias HR; Bouzat C
    Neuropharmacology; 2016 Aug; 107():189-200. PubMed ID: 26926428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allosterically Potentiated
    Miller DR; Khoshbouei H; Garai S; Cantwell LN; Stokes C; Thakur G; Papke RL
    Mol Pharmacol; 2020 Dec; 98(6):695-709. PubMed ID: 33020143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Competitive binding at a nicotinic receptor transmembrane site of two α7-selective positive allosteric modulators with differing effects on agonist-evoked desensitization.
    Collins T; Young GT; Millar NS
    Neuropharmacology; 2011 Dec; 61(8):1306-13. PubMed ID: 21820451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selectivity optimization of substituted 1,2,3-triazoles as α7 nicotinic acetylcholine receptor agonists.
    Arunrungvichian K; Fokin VV; Vajragupta O; Taylor P
    ACS Chem Neurosci; 2015 Aug; 6(8):1317-30. PubMed ID: 25932897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type I and type II positive allosteric modulators of α7 nicotinic acetylcholine receptors induce antidepressant-like activity in mice by a mechanism involving receptor potentiation but not neurotransmitter reuptake inhibition. Correlation with mTOR intracellular pathway activation.
    Targowska-Duda KM; Budzynska B; Michalak A; Wnorowski A; Loland CJ; Maj M; Manetti D; Romanelli MN; Jozwiak K; Biala G; Arias HR
    Eur Neuropsychopharmacol; 2021 Nov; 52():31-47. PubMed ID: 34237657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of alpha7 nicotinic acetylcholine receptor agonists and positive allosteric modulators using the parallel oocyte electrophysiology test station.
    Malysz J; Grønlien JH; Timmermann DB; Håkerud M; Thorin-Hagene K; Ween H; Trumbull JD; Xiong Y; Briggs CA; Ahring PK; Dyhring T; Gopalakrishnan M
    Assay Drug Dev Technol; 2009 Aug; 7(4):374-90. PubMed ID: 19689206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification by virtual screening and functional characterisation of novel positive and negative allosteric modulators of the α7 nicotinic acetylcholine receptor.
    Smelt CLC; Sanders VR; Newcombe J; Burt RP; Sheppard TD; Topf M; Millar NS
    Neuropharmacology; 2018 Sep; 139():194-204. PubMed ID: 30009834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular interactions of type I and type II positive allosteric modulators with the human α7 nicotinic acetylcholine receptor: an in silico study.
    Targowska-Duda KM; Kaczor AA; Jozwiak K; Arias HR
    J Biomol Struct Dyn; 2019 Feb; 37(2):411-439. PubMed ID: 29363414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An allosteric binding site of the α7 nicotinic acetylcholine receptor revealed in a humanized acetylcholine-binding protein.
    Delbart F; Brams M; Gruss F; Noppen S; Peigneur S; Boland S; Chaltin P; Brandao-Neto J; von Delft F; Touw WG; Joosten RP; Liekens S; Tytgat J; Ulens C
    J Biol Chem; 2018 Feb; 293(7):2534-2545. PubMed ID: 29237730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct profiles of alpha7 nAChR positive allosteric modulation revealed by structurally diverse chemotypes.
    Grønlien JH; Håkerud M; Ween H; Thorin-Hagene K; Briggs CA; Gopalakrishnan M; Malysz J
    Mol Pharmacol; 2007 Sep; 72(3):715-24. PubMed ID: 17565004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heteromeric Neuronal Nicotinic Acetylcholine Receptors with Mutant
    Stokes C; Garai S; Kulkarni AR; Cantwell LN; Noviello CM; Hibbs RE; Horenstein NA; Abboud KA; Thakur GA; Papke RL
    J Pharmacol Exp Ther; 2019 Aug; 370(2):252-268. PubMed ID: 31175218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Side Groups Convert the α7 Nicotinic Receptor Agonist Ether Quinuclidine into a Type I Positive Allosteric Modulator.
    Viscarra F; Chrestia JF; Sanchez Y; Pérez EG; Biggin PC; Bouzat C; Bermudez I; López JJ
    ACS Chem Neurosci; 2023 Aug; 14(16):2876-2887. PubMed ID: 37535446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studying Nicotinic Acetylcholine Receptors Using the IonFlux™ Microfluidic-Based Automated Patch-Clamp System with Continuous Perfusion and Fast Solution Exchange.
    Yehia A; Wei H
    Curr Protoc Pharmacol; 2020 Mar; 88(1):e73. PubMed ID: 32068960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of the molecular mechanism of the α7 nicotinic acetylcholine receptor positive allosteric modulator PNU-120596 provides evidence for two distinct desensitized states.
    Williams DK; Wang J; Papke RL
    Mol Pharmacol; 2011 Dec; 80(6):1013-32. PubMed ID: 21885620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diversity of Nicotinic Acetylcholine Receptor Positive Allosteric Modulators Revealed by Mutagenesis and a Revised Structural Model.
    Newcombe J; Chatzidaki A; Sheppard TD; Topf M; Millar NS
    Mol Pharmacol; 2018 Feb; 93(2):128-140. PubMed ID: 29196491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allosteric Agonism of
    Gulsevin A; Papke RL; Stokes C; Garai S; Thakur GA; Quadri M; Horenstein NA
    Mol Pharmacol; 2019 Jun; 95(6):606-614. PubMed ID: 30944209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positive allosteric modulators of α7 nicotinic acetylcholine receptors affect neither the function of other ligand- and voltage-gated ion channels and acetylcholinesterase, nor β-amyloid content.
    Arias HR; Ravazzini F; Targowska-Duda KM; Kaczor AA; Feuerbach D; Boffi JC; Draczkowski P; Montag D; Brown BM; Elgoyhen AB; Jozwiak K; Puia G
    Int J Biochem Cell Biol; 2016 Jul; 76():19-30. PubMed ID: 27129924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A human-specific, truncated α7 nicotinic receptor subunit assembles with full-length α7 and forms functional receptors with different stoichiometries.
    Lasala M; Corradi J; Bruzzone A; Esandi MDC; Bouzat C
    J Biol Chem; 2018 Jul; 293(27):10707-10717. PubMed ID: 29784875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.